Ulisse Biomed Future Growth
Future criteria checks 5/6
Ulisse Biomed is forecast to grow earnings and revenue by 97.2% and 78% per annum respectively.
Key information
97.2%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 31.1% |
| Revenue growth rate | 78.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Dec 2023 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | 1 | 1 | N/A | 1 |
| 12/31/2024 | 1 | 0 | 0 | N/A | 1 |
| 12/31/2023 | 0 | -2 | -2 | N/A | 1 |
| 6/30/2023 | 0 | -2 | -2 | -1 | N/A |
| 3/31/2023 | 0 | -1 | -1 | -1 | N/A |
| 12/31/2022 | 0 | -1 | -1 | -1 | N/A |
| 9/30/2022 | 0 | -1 | N/A | N/A | N/A |
| 6/30/2022 | 0 | -1 | -2 | -1 | N/A |
| 3/31/2022 | 0 | -1 | -2 | -1 | N/A |
| 12/31/2021 | 0 | -1 | -1 | 0 | N/A |
| 9/30/2021 | 0 | 0 | N/A | N/A | N/A |
| 6/30/2021 | 1 | 0 | 0 | 1 | N/A |
| 3/31/2021 | 1 | 0 | 0 | 0 | N/A |
| 12/31/2020 | 1 | 0 | -1 | -1 | N/A |
| 12/31/2019 | 0 | -1 | 0 | 0 | N/A |
| 12/31/2018 | 0 | -2 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UBM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: UBM is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: UBM is expected to become profitable in the next 3 years.
Revenue vs Market: UBM's revenue (78% per year) is forecast to grow faster than the Italian market (3.6% per year).
High Growth Revenue: UBM's revenue (78% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if UBM's Return on Equity is forecast to be high in 3 years time